Currently, the 750mcg teriparatide injection formulation is accessible in Australia however the availability is conditional. Typically , it’s prescribed for patients with significant osteoporosis who display an lack to respond adequately to, or do not tolerate, conventional therapies. The cost can vary significantly depending on the pharmacy , in